Early FDG-PET Assessment in Combination With Clinical Risk Scores Determines Prognosis in Recurring Lymphoma

Blood - United States
doi 10.1182/blood-2005-11-006957
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society of Hematology

Related search

FDG-PET Scan in Lymphoma: Silver Anniversary

Clinical and Translational Imaging
Nuclear MedicineRadiologyImaging
2015English

FDG-PET as a Biomarker for Early Response in Diffuse Large B-Cell Lymphoma as Well as in Hodgkin Lymphoma? Ready for Implementation in Clinical Practice?

Haematologica
Hematology
2016English

Utility of Baseline Assessment With FDG-PET-CT Compared With CT Scanning in People With Diffuse Large B-Cell Lymphoma (DLBCL)

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2017English

Prognostic Value of Baseline FDG Pet Parameters in High Risk Diffuse Large B-Cell Lymphoma Patients

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Interest of FDG-PET in the Management of Mantle Cell Lymphoma

Frontiers in Medicine
Medicine
2019English

Predictive Potential of FDG-PET/CT for Histological Transformation in Patients With Indolent Lymphoma

Advances in Molecular Imaging
2014English

Dual-Time-Point 18f-FDG PET/CT in Patients With Colorectal Cancer: Clinical Value of Early Delayed Scanning

Annals of Nuclear Medicine
MedicineNuclear MedicineRadiologyImaging
2012English

On the Added Value of Baseline FDG-PET in Malignant Lymphoma

Molecular Imaging and Biology
Cancer ResearchNuclear MedicineRadiologyImagingOncology
2009English

Clinical, FDG and Amyloid PET Imaging in Posterior Cortical Atrophy

Journal of Neurology
Neurology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy